EMAIL THIS PAGE TO A FRIEND

Nature communications

MRI detection of breast cancer micrometastases with a fibronectin-targeting contrast agent.


PMID 26264658

Abstract

Metastasis is the primary cause of death in breast cancer patients. Early detection of high-risk breast cancer, including micrometastasis, is critical in tailoring appropriate and effective interventional therapies. Increased fibronectin expression, a hallmark of epithelial-to-mesenchymal transition, is associated with high-risk breast cancer and metastasis. We have previously developed a penta-peptide CREKA (Cys-Arg-Glu-Lys-Ala)-targeted gadolinium-based magnetic resonance imaging (MRI) contrast agent, CREKA-Tris(Gd-DOTA)3 (Gd-DOTA (4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododecyl gadolinium), which binds to fibrin-fibronectin complexes that are abundant in the tumour microenvironment of fast-growing breast cancer. Here we assess the capability of CREKA-Tris(Gd-DOTA)3 to detect micrometastasis with MRI in co-registration with high-resolution fluorescence cryo-imaging in female mice bearing metastatic 4T1 breast tumours. We find that CREKA-Tris(Gd-DOTA)3 provides robust contrast enhancement in the metastatic tumours and enables the detection of micrometastases of size <0.5 mm, extending the detection limit of the current clinical imaging modalities. These results demonstrate that molecular MRI with CREKA-Tris(Gd-DOTA)3 may facilitate early detection of high-risk breast cancer and micrometastasis in the clinic.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

AV40173
Anti-ACTB antibody produced in rabbit, affinity isolated antibody, lyophilized powder
SAB2100037
Anti-ACTB antibody produced in rabbit, affinity isolated antibody
GW23014 Anti-Actin, Cytoplasmic 1 antibody produced in chicken, affinity isolated antibody, buffered aqueous solution
SAB3500350
Anti-β-Actin antibody produced in chicken, affinity isolated antibody, buffered aqueous solution
SAB4500974
Anti-Fibronectin 1, C-Terminal antibody produced in rabbit, affinity isolated antibody
GW20021F Anti-Fibronectin antibody produced in chicken, affinity isolated antibody, buffered aqueous solution
F3648
Anti-Fibronectin antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
SAB1405825
Anti-FN1 antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
AV41490
Anti-FN1 antibody produced in rabbit, affinity isolated antibody
HPA027066
Anti-FN1 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB2104810
Anti-FN1, (N-terminal) antibody produced in rabbit, affinity isolated antibody
L9504
D-Luciferin, synthetic
C11H8N2O3S2
L6152
D-Luciferin, synthetic, BioXtra, ≥99% (HPLC)
C11H8N2O3S2
CDS019936
Isoflurane, AldrichCPR
C3H2ClF5O
WH0000060M1
Monoclonal Anti-ACTB antibody produced in mouse, clone 3G4-F9, purified immunoglobulin, buffered aqueous solution
SAB1403520
Monoclonal Anti-ACTB antibody produced in mouse, clone 1E7, purified immunoglobulin, buffered aqueous solution
A2228
Monoclonal Anti-β-Actin antibody produced in mouse, clone AC-74, purified immunoglobulin, buffered aqueous solution
F7387 Monoclonal Anti-Fibronectin antibody produced in mouse, clone FN-15, ascites fluid
F0916 Monoclonal Anti-Fibronectin antibody produced in mouse, clone IST-4, ascites fluid
F0791 Monoclonal Anti-Fibronectin antibody produced in mouse, clone IST-3, ascites fluid